Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug-Susceptible Tuberculosis Guidelines: Caveats and Controversies

This webinar is second in the series discussing, Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug-Susceptible Tuberculosis Guidelines: Caveats and Controversies.

To view the webinar click, Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug-Susceptible Tuberculosis Guidelines: Caveats and Controversies